By Kayon Raynor
A Jamaican athlete returned an adverse analytical finding for a banned drug during competition in June.
One month before the next IAAF World Championships, RJR Sports can report that a Jamaican athlete, who is destined to compete in Doha, Qatar has been cited for an adverse analytical finding for a banned diuretic.
According to the one impeccable source, it's understood that the substance found in the athlete’s “A” sample was contained in a cold and flu medication, which was tested at the WADA accredited lab in Montreal.
The athlete's team has since had the medication containing the banned substance tested by a lab in North America – NSF International Labs in Michigan, USA.
Under the World Anti-doping Agency and IAAF doping rules, the athlete is facing the possibility of a four-year ban for this first offence if the athlete is found guilty.
Another source, with knowledge of the matter, has informed RJR Sports that the tainted sample was taken at the National Senior Trials in Kingston from June 20 to 23, where the sprinter secured a top three finish.
One of the sources, who spoke on condition of not being named, given confidentiality issues concerning doping cases, said the sprinter “requested that the “B” sample be tested since the first week of August."
The source also shared that the athlete was informed of the "A" sample result on July 25.
Pressed about the matter not being publicized by the Athletics Integrity Unit, the other source indicated: “AIU wouldn’t put out anything on their website until at least the "B" sample comes back positive,” because until the "B” sample comes back positive, nothing is considered a positive, unless the athlete accepts the “A” sample as being positive."
RJR Sports was unable to reach the athlete’s team on Monday.
Efforts by RJR to contact JAAA President Dr. Warren Blake and Alexander Williams, who chairs JADCo, have been unsuccessful.
All feeds
